Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Caffeine on Cerebrovascular and Retinal Reactivity
NCT04730193Phase 1Completed
- Sponsor
- University of Oklahoma
- Start
- Feb 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial comparing Caffeine with Placebo (2 arms). Primary endpoints: Modified Caffeine Research Visual Analogue Scales, Static retinal vessel assessment and 3 more. Started Feb 2021; status: completed.
02
Drugs
caffeine
Beyond the preview
Go deeper on NCT04730193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04730193.